| Particulars |
| Company Name |
Astrazeneca Pharma India Ltd |
Year End |
202503 |
| Full Year |
| Equity (Rs Cr.) |
5.00 |
B.V. Rs |
319.60 |
| Sales Rs Cr. |
1,716.29 |
NP Rs Cr. |
175.13 |
| NP Var% |
17.00 |
Div% |
1,600.00 |
| CPS Rs |
86.00 |
EPS Rs |
70.10 |
| Traded Value(Rs Lakhs) |
39.47 |
52 Week High |
10,653.00 |
| 52 Week Low |
6,502.00 |
Price BSE |
8,252.00 |
| Price NSE |
8,264.00 |
Market Capital(Rs Cr.) |
20,629.88 |
| P/C Ratio |
95.90 |
P/E Ratio |
117.80 |
| Price Vs.BV |
25.82 |
|
| Latest Quarter |
| Year End |
202509 |
Sales Rs Cr. |
559.09 |
| NP Rs Cr. |
58.13 |
NP Var % |
51.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
1,484.51 |
| OPM |
9.59 |
NP |
128.73 |
| NP Var% |
79.57 |
EPS |
92.47 |
| PE |
89.24 |
|
|